The DEA Action, Plainly
On 6 July 2026 the DEA published notices of intent to place 7-hydroxymitragynine (7-OH) above a specified threshold, and three related substances (mitragynine pseudoindoxyl, MGM-15, MGM-16), in Schedule I of the Controlled Substances Act. The notices state the temporary scheduling order could publish on or after 5 August 2026, takes effect the day it publishes, and runs for two years with a possible one-year extension.
As of October 11, 2026, that final order had not appeared in the Federal Register, which means the window is open and it can drop on any business day. When it does, concentrated 7-OH products become federally illegal to manufacture, distribute, and possess, everywhere in the United States, immediately.
One part of the action has already landed. On 26 August 2026 the DEA published a separate temporary order placing the three related substances (mitragynine pseudoindoxyl, MGM-15 and MGM-16) in Schedule I, effective the same day. The 7-OH threshold itself stayed open: the comment period on the proposed threshold was extended to 10 September 2026.
Does this ban regular kratom? No. The federal thresholds (0.05% 7-OH for plant material, and 0.05% or 1 mg per article for extracts, tablets, and edibles) deliberately exempt natural kratom leaf. The action targets the concentrated and semi-synthetic 7-OH products sold as tablets, shots, and gummies. State law is stricter in places: the six states that ban kratom itself ban every form, leaf included.
State Bans and Restrictions
A snapshot as of October 11, 2026. State law is moving monthly on 7-OH. Treat this as a map, not legal advice, and verify your own state's current rule before relying on it.
A Ban Ends the Supply. It Does Not End the Dependence.
7-OH acts on the same receptors as opioids, and daily users can experience a genuine opioid-type withdrawal when the product disappears. Clinical reports describe onset within six to eight hours of the last dose. When a state ban lands, that clock starts for a lot of people on the same day.
Two things matter more than anything else. First: do not substitute street opioids. The fentanyl risk is immediate and it is how a product ban becomes an overdose statistic. Second: plan the exit before the supply runs out, with a clinician, not after. A managed transition is a medical routine; an abrupt cold-turkey stop in a parked car is not.
Our Kratom & 7-OH Recovery program is a 10 to 12 day medically supervised protocol built around exactly this pharmacology: full cardiac screening, a medically directed transition, and 90 days of integration support. The deeper clinical picture, including why 7-OH withdrawal behaves like opioid withdrawal, is on the 7-OH dependence page.
Taking prescription medication? Some medications need a supervised taper or washout period before ibogaine. Check your medications against our interaction guide, or review the contraindications. Never stop or change a medication without your prescriber. The transition plan is designed with our medical team before you travel.
Ban Questions
7-OH and Kratom Bans, Answered
Sources
DEA press release, "DEA to Temporarily Schedule 7-OH and Related Substances" (Jul 1, 2026) · Federal Register, temporary placement notices for 7-hydroxymitragynine and related substances (published 6 July 2026) · Congressional Research Service, "Temporary Control of 7-Hydroxymitragynine (7-OH) and Related Substances" (LSB11457) · FDA, "Hiding in Plain Sight: 7-OH Products" · state statutes and emergency orders as reported through October 11, 2026. Retrieved and verified October 11, 2026. This page is general information, not legal or medical advice.